Spasmodic Dysphonia Pain
Spasmodic Dysphonia Pain Study
Sponsor: Mayo Clinic
A PHASE2/PHASE3 clinical study on Spasmodic Dysphonia, this trial is completed. The trial is conducted by Mayo Clinic and has accumulated 12 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jun 2024 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
Status: Recruiting → Completed · Phase: NA → PHASE2_PHASE3
-
Feb 2023 — Jun 2024 [monthly]
Recruiting NA
-
Nov 2022 — Feb 2023 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Oct 2021 — Nov 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
-
May 2021 — Jun 2021 [monthly]
Not Yet Recruiting NA
-
Mar 2021 — May 2021 [monthly]
Not Yet Recruiting NA
-
Feb 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .